GlassScriptPhysician profile
Nikhil Iyer
NPI 1326495698
$17,969.99
in general payments reported to CMS, 2019-2025
25 companies · $274 in 2025
The $274 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $10K · 2021: $767 · 2022: $2,718 · 2023: $3,252 · 2024: $851 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,292 · Travel and Lodging: $1,085.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,292.05 |
| Travel and Lodging | $1,085.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $10,107.90 | 2020 | |
| Medtronic, INC. | $2,678.00 | 2021-2025 | Synchromedii, Intellis Adaptivestim |
| Relievant Medsystems, INC. | $1,449.05 | 2022 | |
| Abbott Laboratories | $1,213.21 | 2021-2023 | Proclaim, Eterna |
| Collegium Pharmaceutical, INC. | $444.69 | 2022-2024 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $368.88 | 2022-2024 | Relistor |
| Nevro Corp. | $203.91 | 2022-2023 | Senza |
| Boston Scientific Corporation | $203.32 | 2022-2023 | Wavewriter Alpha Prime 16 |
| Globus Medical, INC. | $172.06 | 2022-2025 | Senza |
| Saluda Medical Americas, INC. | $141.80 | 2024-2025 | Evoke |
| Abbvie INC. | $136.14 | 2023 | |
| Pfizer INC. | $115.36 | 2023-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $101.06 | 2022 | |
| Painteq LLC | $96.77 | 2024 | Painteq |
| Azurity Pharmaceuticals, INC. | $88.32 | 2023-2024 | Horizant, Horizant |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $84.29 | 2023 | Ztlido |
| Redhill Biopharma INC. | $63.97 | 2022-2023 | Movantik |
| Amgen INC. | $61.94 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $59.88 | 2022-2023 | Ajovy |
| Hikma Pharmaceuticals USA | $53.87 | 2022 | |
| Vertos Medical, INC. | $41.23 | 2023-2024 | Mild Device Kit |
| Depuy Synthes Sales INC. | $25.79 | 2022 | |
| Spr Therapeutics, INC | $20.04 | 2022 | |
| Lilly USA, LLC | $19.59 | 2023 | Emgality, Reyvow |
| Forte Bio-Pharma LLC | $18.92 | 2023 | Prolate, Nalocet |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikhil Iyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.